The use of validated quality of life questionnaries in patients with neuroendocrine tumors. the results of the national multicenter study (SAS-LAR-QOL) of 93 patients

Background: Neuroendocrine tumors (NET) are rare malignancies. There are limited data of the effectiveness of the long-term somatostatin analogue treatment for the quality of life in our country. The objective of our observational study was to assess the change of patients' quality of life receiving long-term) using two validated®somatostatin-analogue treatment (Sandostatin-LAR questionnaries. Patients and Methods: A multicenter observational study was performed between 2005–2007 in Hungary. 93 patients were included, among them there were 58 men and 35 women. The mean age at the diagnosis 12.7 years, 54 patient…